Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer’s Disease High-Risk APOE4 Variant and Replace with Protective APOE2

HUMAN GENE THERAPY · Published 2026-08-02 · DOI 10.1177/10430342261473427

Authors (3)

Kalpita R. Karan, Neil R. Hackett, Ronald G. Crystal

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Karan, K., Hackett, N., Crystal, R. (2026). Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer’s Disease High-Risk APOE4 Variant and Replace with Protective APOE2. HUMAN GENE THERAPY. https://doi.org/10.1177/10430342261473427

Related articles

• Prime Editing of Alzheimer’s Disease High-Risk APOE4 Allele by Brain-Directed Adeno-Associated Virus Vectors · HUMAN GENE THERAPY · 2025 · Cites or is cited by this article · Same journal
• Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells · HUMAN GENE THERAPY · 2026 · Same journal
• Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors · HUMAN GENE THERAPY · 2026 · Same journal
• Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta ) · HUMAN GENE THERAPY · 2026 · Same journal
• High Prevalence of Preexisting Neutralizing Antibodies Against Adeno-Associated Virus Capsids in Mongolian People with Hemophilia · HUMAN GENE THERAPY · 2026 · Same journal
• Quantification of Lentiviral Vectors with Nucleic Acid Dyes · HUMAN GENE THERAPY · 2026 · Same journal
• CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences · HUMAN GENE THERAPY · 2026 · Same journal
• A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions · HUMAN GENE THERAPY · 2026 · Same journal
• Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases · HUMAN GENE THERAPY · 2026 · Same journal
• Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing · HUMAN GENE THERAPY · 2026 · Same journal